PT Bio Farma Of Indonesia Faces Cheaper Chinese Vaccines
This article was originally published in PharmAsia News
Executive Summary
Indonesia's PT Bio Farma, a state-owned drug-maker mainstay, is preparing itself against what it calls an onslaught of competing vaccines from China over the next three years